Illumina CFO to Depart, Summit Therapeutics' Ankur Dhingra Named Successor

Illumina said on Tuesday Chief Financial Officer Joydeep Goswami will leave the San Diego-based gene sequencing company and be succeeded by former Summit Therapeutics' executive Ankur Dhingra.

Related Keywords

San Diego ,California ,United States ,Ankur Dhingra ,Mike Blake ,Carl Icahn ,Joydeep Goswami ,Agilent Technologies ,Reuters ,Tuesday Chief Financial Officer Joydeep Goswami ,San Diego Based ,Summit Therapeutic ,